Atezolizumab plus bevacizumab and chemotherapy as first-line therapy for cervical cancer: a cost-effectiveness analysis in the US - Lin, Yingtao; Li, Cijuan; Wang, Chang; Chen, Jian; Huang, Yuanqing (Frontiers in Immunology, 2024)